Materials and methods for treating fibrosis in a mammal are disclosed. The methods comprise administering to a mammal a composition comprising a therapeutically effective amount of a zvegf3 antagonist in combination with a pharmaceutically acceptable delivery vehicle. Zvegf3 antagonists include anti-zvegf3 antibodies, mitogenically inactive receptor-binding zvegf3 variant polypeptides, and inhibitory polynucleotides. Within one embodiment of the invention the fibrosis is liver fibrosis.

 
Web www.patentalert.com

< Implant surface preparation

> Methods for production of growth-promoting proteins and peptides for kidney epithelial cells

> Method for installation of dynamic, single-lock anterior cervical plate system having non-detachably fastened and moveable segments

~ 00528